Page last updated: 2024-09-03
sr 48692 and Glioma
sr 48692 has been researched along with Glioma in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cui, H; Dai, Y; Feng, H; Gong, X; Ouyang, Q; Xiao, H; Xu, L; Xu, M; Yi, L; Zhou, J | 1 |
Other Studies
1 other study(ies) available for sr 48692 and Glioma
| Article | Year |
|---|---|
Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Glioma; Humans; Mice; Neoplasm Invasiveness; Neurotensin; Phosphorylation; Prognosis; Protein Precursors; Pyrazoles; Quinolines; Receptors, Neurotensin | 2015 |